CVS
36
3
AIV
47
-3
SYF
78
7
BA
42
-2
SIG
41
-2
EQR
33
3
HPE
40
4
BXP
38
4
GME
65
3
MDT
59
2
LYB
34
16
PFG
31
3
ACN
45
-2
JNPR
67
2
BAC
42
3
GT
41
2
FMC
33
11
AAL
41
-4
MMM
42
5
NVDA
56
5
CVS
36
3
AIV
47
-3
SYF
78
7
BA
42
-2
SIG
41
-2
EQR
33
3
HPE
40
4
BXP
38
4
GME
65
3
MDT
59
2
LYB
34
16
PFG
31
3
ACN
45
-2
JNPR
67
2
BAC
42
3
GT
41
2
FMC
33
11
AAL
41
-4
MMM
42
5
NVDA
56
5
Financhill
Back

Acrivon Therapeutics 10K Form

Sell
37

ACRV
Acrivon Therapeutics

Last Price:
$6.60
Seasonality Move:
28.76%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ACRV News And Ratings

See the #1 stock for the next 7 days that we like better than ACRV

ACRV Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-18.3M
Price / Cash Flow: 0
Annual Sales: $6.32
Price / Book: 1.05

Profitability

EPS (TTM): -2.71000
Net Income (TTM): $-77M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Acrivon Therapeutics Earnings Forecast

Key Acrivon Therapeutics Financial Ratios

  • Per Share Earnings over the last 4 years have been positive in 1 years.

Acrivon Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ACRV
Website: acrivon.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ACRV Technical Analysis vs Fundamental Analysis

Sell
37
Acrivon Therapeutics (ACRV) is a Sell

Is Acrivon Therapeutics a Buy or a Sell?